Madrid, Spain: Cannabis’ active components show promise in halting the progression of certain neurodegerative disorders and should be evaluated in clinical trials, according to a review published online in the British Journal of Pharmacology. An international...
There are some positive anecdotal reports of therapeutic response to cannabis in Tourette’s syndrome, dystonia and tardive dyskinesia. The use in Tourette’s syndrome is currently being investigated in clinical studies. Many patients achieve a modest...
